glp 1/gip agonist New Weight-Loss Drugs Are Poised to Upend Preventive Cardiology Care in Patients With Obesity and Overweight GLP-1/GIP Receptor Agonists and Diabetic

Description

For overweight individuals or those with obesity, weight reduction significantly lowers high blood pressure and high cholesterol

Mast cell stabilizer (MCAS Connection): GLP-1 receptors are also found on mast cells, and recent studies have shown that GLP-1 RA drugs prevent overactive mast cell degranulation

"Finding new and better treatments is critically important to help people live healthier lives." References Nirupam M Srinivasan, Mehdi Farokhnia, Lisa A Farinelli, Anna Ferrulli, Lorenzo Leggio, GLP-1 Therapeutics and Their Emerging Role in Alcohol and Substance Use Disorders: An Endocrinology Primer, Journal of the Endocrine Society , Volume 9, Issue 11, November 2025, bvaf141,